Skip to main content

Articles

Page 79 of 94

  1. We have shown previously that HIV actively and selectively packages the spliced HIV RNAs into progeny virions. In the present study, by using a RT-QPCR and QPCR strategies, we show that spliced viral RNAs are ...

    Authors: Laurent Houzet, Zakia Morichaud and Marylène Mougel
    Citation: Retrovirology 2007 4:30
  2. A primary concern when targeting HIV-1 RNA by means of antisense related technologies is the accessibility of the targets. Using a library selection approach to define the most accessible sites for 20-mer olig...

    Authors: Martin R Jakobsen, Joost Haasnoot, Jesper Wengel, Ben Berkhout and Jørgen Kjems
    Citation: Retrovirology 2007 4:29
  3. Centrosomes are the major microtubule organizing structures in vertebrate cells. They localize in close proximity to the nucleus for the duration of interphase and play major roles in numerous cell functions. ...

    Authors: Philippe V Afonso, Alessia Zamborlini, Ali Saïb and Renaud Mahieux
    Citation: Retrovirology 2007 4:27
  4. We reported previously on the emergence and clinical implications of simian immunodeficiency virus (SIVmac251) mutants with a K65R mutation in reverse transcriptase (RT), and the role of CD8+ cell-mediated imm...

    Authors: Koen KA Van Rompay, Jeffrey A Johnson, Emily J Blackwood, Raman P Singh, Jonathan Lipscomb, Timothy B Matthews, Marta L Marthas, Niels C Pedersen, Norbert Bischofberger, Walid Heneine and Thomas W North
    Citation: Retrovirology 2007 4:25
  5. Pakistan, the second most populous Muslim nation in the world, has started to finally experience and confront the HIV/AIDS epidemic. The country had been relatively safe from any indigenous HIV cases for aroun...

    Authors: Mohammad A Rai, Haider J Warraich, Syed H Ali and Vivek R Nerurkar
    Citation: Retrovirology 2007 4:22
  6. APOBEC3G (hA3G) is a newly discovered cellular factor of innate immunity that inhibits HIV replication in vitro. Whether hA3G conferrs protection against HIV in vivo is not known. To investigate the possible anti...

    Authors: Xia Jin, Hulin Wu and Harold Smith
    Citation: Retrovirology 2007 4:20
  7. We have studied the effects associated with two single amino acid substitution mutations in HIV-1 capsid (CA), the E98A and E187G. Both amino acids are well conserved among all major HIV-1 subtypes. HIV-1 infe...

    Authors: Samir Abdurahman, Stefan Höglund, Anders Höglund and Anders Vahlne
    Citation: Retrovirology 2007 4:19
  8. In 1871, the observation of yellowish nodules in the enlarged spleen of a cow was considered to be the first reported case of bovine leukemia. The etiological agent of this lymphoproliferative disease, bovine ...

    Authors: Nicolas Gillet, Arnaud Florins, Mathieu Boxus, Catherine Burteau, Annamaria Nigro, Fabian Vandermeers, Hervé Balon, Amel-Baya Bouzar, Julien Defoiche, Arsène Burny, Michal Reichert, Richard Kettmann and Luc Willems
    Citation: Retrovirology 2007 4:18
  9. The discovery of diketoacid-containing derivatives as inhibitors of HIV-1 Integrase (IN) (IN inhibitors, IINs) has played a major role in validating this enzyme as an important target for antiretroviral therap...

    Authors: Maurizio Cianfriglia, Maria Luisa Dupuis, Agnese Molinari, Antonio Verdoliva, Roberta Costi, Clementina Maria Galluzzo, Mauro Andreotti, Andrea Cara, Roberto Di Santo and Lucia Palmisano
    Citation: Retrovirology 2007 4:17
  10. Expression of the HIV-1 vpr gene in human and fission yeast cells displays multiple highly conserved activities, which include induction of cell cycle G2 arrest and cell death. We have previously characterized a ...

    Authors: Zsigmond Benko, Dong Liang, Emmanuel Agbottah, Jason Hou, Lorena Taricani, Paul G Young, Michael Bukrinsky and Richard Y Zhao
    Citation: Retrovirology 2007 4:16
  11. Human immunodeficiency virus type 1 (HIV-1) can be inhibited by means of RNA silencing or interference (RNAi) using synthetic short interfering RNAs (siRNAs) or gene constructs encoding short hairpin RNAs (shR...

    Authors: Pavlina Konstantinova, Olivier ter Brake, Joost Haasnoot, Peter de Haan and Ben Berkhout
    Citation: Retrovirology 2007 4:15
  12. The human T-cell leukemia virus type I (HTLV-I) basic leucine-zipper factor (HBZ) has previously been shown to modulate transcriptional activity of Jun family members. The presence of a novel isoform of HBZ, t...

    Authors: Patrick Hivin, Jihane Basbous, Frédéric Raymond, Daniel Henaff, Charlotte Arpin-André, Véronique Robert-Hebmann, Benoit Barbeau and Jean-Michel Mesnard
    Citation: Retrovirology 2007 4:14
  13. HIV-responsive expression vectors are all based on the HIV promoter, the long terminal repeat (LTR). While responsive to an early HIV protein, Tat, the LTR is also responsive to cellular activation states and ...

    Authors: Yuntao Wu, Margaret H Beddall and Jon W Marsh
    Citation: Retrovirology 2007 4:12
  14. The Deltaretrovirus genus comprises viruses that infect humans (HTLV), various simian species (STLV) and cattle (BLV). HTLV-I is the main causative agent in adult T-cell leukemia in endemic areas and some of t...

    Authors: Thomas Burmeister, Stefan Schwartz, Michael Hummel, Dieter Hoelzer and Eckhard Thiel
    Citation: Retrovirology 2007 4:11
  15. Recent characterizations of methyl transferases as regulators of cellular processes have spurred investigations into how methylation events might influence the HIV-1 life cycle. Emerging evidence suggests that...

    Authors: Venkat RK Yedavalli and Kuan-Teh Jeang
    Citation: Retrovirology 2007 4:9
  16. Little is known about the progression and pathogenesis of HIV-1 infection within the male genital tract (MGT), particularly during the early stages of infection.

    Authors: Miranda Shehu-Xhilaga, Stephen Kent, Jane Batten, Sarah Ellis, Joel Van der Meulen, Moira O'Bryan, Paul U Cameron, Sharon R Lewin and Mark P Hedger
    Citation: Retrovirology 2007 4:7
  17. Chloroquine (CQ) has been shown to inhibit HIV-1 replication in vitro as well as in vivo and has been proposed to alter the glycosylation pattern of the gp120 envelope. These activities indicate that the compound...

    Authors: Marloes A Naarding, Elly Baan, Georgios Pollakis and William A Paxton
    Citation: Retrovirology 2007 4:6
  18. Retroviral insertion into a host genome is a powerful tool not only for the discovery of cancer genes, but also for the discovery of potential oncogenic noncoding RNAs. In a large-scale mouse T lymphocyte tumo...

    Authors: Amy M Lum, Bruce B Wang, Lauri Li, Namitha Channa, Gabor Bartha and Matthias Wabl
    Citation: Retrovirology 2007 4:5
  19. Oncoretrovirus, but not lentivirus, displays a high transcriptional readthrough activity in the 3' long terminal repeat (LTR) (Zaiss et al. J. Virol. 76, 7209–7219, 2002). However, the U3-deleted, self-inactiv...

    Authors: Qing Yang, Aurore Lucas, Sodany Son and Lung-Ji Chang
    Citation: Retrovirology 2007 4:4
  20. Vpx is a non-structural protein coded by members of the SIVSM/HIV-2 lineage that is believed to have originated by duplication of the common vpr gene present in primate lentiviruses. Vpx is incorporated into viri...

    Authors: Caroline Goujon, Lise Rivière, Loraine Jarrosson-Wuilleme, Jeanine Bernaud, Dominique Rigal, Jean-Luc Darlix and Andrea Cimarelli
    Citation: Retrovirology 2007 4:2
  21. We have obtained the 1.7 Ã… crystal structure of FIV protease (PR) in which 12 critical residues around the active site have been substituted with the structurally equivalent residues of HIV PR (12X FIV PR). Th...

    Authors: Holly Heaslet, Ying-Chuan Lin, Karen Tam, Bruce E Torbett, John H Elder and C David Stout
    Citation: Retrovirology 2007 4:1
  22. This year-end editorial discusses several points including the recent Libyan verdict sentencing five Bulgarian nurses and a Palestinian doctor to death for allegedly infecting 426 children with HIV. It also co...

    Authors: Kuan-Teh Jeang
    Citation: Retrovirology 2006 3:99

Annual Journal Metrics

  • 2022 Citation Impact
    3.3 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.004 - SNIP (Source Normalized Impact per Paper)
    0.892 - SJR (SCImago Journal Rank)

    2023 Speed
    8 days submission to first editorial decision for all manuscripts (Median)
    83 days submission to accept (Median)

    2023 Usage 
    932,795 downloads
    667 Altmetric mentions